BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21276207)

  • 1. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166).
    Fan JG; Jia JD; Li YM; Wang BY; Lu LG; Shi JP; Chan LY;
    J Dig Dis; 2011 Feb; 12(1):38-44. PubMed ID: 21276207
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological features of non-alcoholic fatty liver disease: what is important?
    Hashimoto E; Tokushige K; Farrell GC
    J Gastroenterol Hepatol; 2012 Jan; 27(1):5-7. PubMed ID: 22188024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update of the management and prognosis of nonalcoholic fatty liver disease].
    Yoneda M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jan; 111(1):35-41. PubMed ID: 24390257
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the diagnosis and management of alcoholic liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 167-170).
    Li YM; Fan JG; Wang BY; Lu LG; Shi JP; Niu JQ; Shen W;
    J Dig Dis; 2011 Feb; 12(1):45-50. PubMed ID: 21276208
    [No Abstract]   [Full Text] [Related]  

  • 5. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2013 Dec; 19(4):325-48. PubMed ID: 24459637
    [No Abstract]   [Full Text] [Related]  

  • 6. [The key target of Chinese medicine treatment on alcoholic and nonalcoholic fatty liver disease: the gut].
    Hu YY; Peng JH; Feng Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1269-72. PubMed ID: 22013810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic syndrome and nonalcoholic fatty liver diseases in children].
    Zakharova IN; Zvenigorodskaia LA; Iablochkova SV
    Eksp Klin Gastroenterol; 2011; (11):44-8. PubMed ID: 22629718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease: A Silent Epidemic.
    Sivell C
    Gastroenterol Nurs; 2019; 42(5):428-434. PubMed ID: 31574071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease].
    Zeng MD; Wang BY; Chen CW; Shi RH; Li YM; Hou XH; Xuan SY; Zou XP; Li YY; Jiang JJ; Song ZY; Fang JG; Mao YM
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):362-6. PubMed ID: 21645445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].
    Takamura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):836-44. PubMed ID: 23772495
    [No Abstract]   [Full Text] [Related]  

  • 12. A 2012 clinical update for internists in adult nonalcoholic fatty liver disease.
    Younossi ZM; Venkatesan C
    Panminerva Med; 2012 Mar; 54(1):29-37. PubMed ID: 22278114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus on integrative medical diagnosis and treatment of non-alcoholic fatty liver disease].
    ;
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):155-8. PubMed ID: 21425564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of non-alcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi].
    Liu T; Tang ZP; Ji G
    Zhong Xi Yi Jie He Xue Bao; 2011 Feb; 9(2):135-7. PubMed ID: 21288446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
    Loria P; Adinolfi LE; Bellentani S; Bugianesi E; Grieco A; Fargion S; Gasbarrini A; Loguercio C; Lonardo A; Marchesini G; Marra F; Persico M; Prati D; Baroni GS;
    Dig Liver Dis; 2010 Apr; 42(4):272-82. PubMed ID: 20171943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How big a problem is non-alcoholic fatty liver disease?
    Anstee QM; McPherson S; Day CP
    BMJ; 2011 Jul; 343():d3897. PubMed ID: 21768191
    [No Abstract]   [Full Text] [Related]  

  • 17. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
    Eslam M; Sarin SK; Wong VW; Fan JG; Kawaguchi T; Ahn SH; Zheng MH; Shiha G; Yilmaz Y; Gani R; Alam S; Dan YY; Kao JH; Hamid S; Cua IH; Chan WK; Payawal D; Tan SS; Tanwandee T; Adams LA; Kumar M; Omata M; George J
    Hepatol Int; 2020 Dec; 14(6):889-919. PubMed ID: 33006093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nonalcoholic fatty liver disease in children the same disease as in adults?
    Hsu E; Murray K
    Clin Liver Dis; 2012 Aug; 16(3):587-98. PubMed ID: 22824482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From NAFLD in clinical practice to answers from guidelines.
    Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
    J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.